These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 29296692)

  • 1. Targeted deep sequencing in polycythemia vera and essential thrombocythemia.
    Tefferi A; Lasho TL; Guglielmelli P; Finke CM; Rotunno G; Elala Y; Pacilli A; Hanson CA; Pancrazzi A; Ketterling RP; Mannarelli C; Barraco D; Fanelli T; Pardanani A; Gangat N; Vannucchi AM
    Blood Adv; 2016 Nov; 1(1):21-30. PubMed ID: 29296692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management.
    Tefferi A; Barbui T
    Am J Hematol; 2017 Jan; 92(1):94-108. PubMed ID: 27991718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted deep sequencing in primary myelofibrosis.
    Tefferi A; Lasho TL; Finke CM; Elala Y; Hanson CA; Ketterling RP; Gangat N; Pardanani A
    Blood Adv; 2016 Dec; 1(2):105-111. PubMed ID: 29296803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Risk Assessment in Myeloproliferative Neoplasms.
    Tefferi A; Vannucchi AM
    Mayo Clin Proc; 2017 Aug; 92(8):1283-1290. PubMed ID: 28778261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic mutations of calreticulin in myeloproliferative neoplasms.
    Klampfl T; Gisslinger H; Harutyunyan AS; Nivarthi H; Rumi E; Milosevic JD; Them NC; Berg T; Gisslinger B; Pietra D; Chen D; Vladimer GI; Bagienski K; Milanesi C; Casetti IC; Sant'Antonio E; Ferretti V; Elena C; Schischlik F; Cleary C; Six M; Schalling M; Schönegger A; Bock C; Malcovati L; Pascutto C; Superti-Furga G; Cazzola M; Kralovics R
    N Engl J Med; 2013 Dec; 369(25):2379-90. PubMed ID: 24325356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of an NGS-based 28-gene panel in myeloproliferative neoplasms reveals distinct mutation patterns in essential thrombocythaemia, primary myelofibrosis and polycythaemia vera.
    Delic S; Rose D; Kern W; Nadarajah N; Haferlach C; Haferlach T; Meggendorfer M
    Br J Haematol; 2016 Nov; 175(3):419-426. PubMed ID: 27447873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing concepts of diagnostic criteria of myeloproliferative disorders and the molecular etiology and classification of myeloproliferative neoplasms: from Dameshek 1950 to Vainchenker 2005 and beyond.
    Michiels JJ; Berneman Z; Schroyens W; De Raeve H
    Acta Haematol; 2015; 133(1):36-51. PubMed ID: 25116092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostication in Philadelphia Chromosome Negative Myeloproliferative Neoplasms: a Review of the Recent Literature.
    Zhou A; Afzal A; Oh ST
    Curr Hematol Malig Rep; 2017 Oct; 12(5):397-405. PubMed ID: 28948488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted next-generation sequencing in blast phase myeloproliferative neoplasms.
    Lasho TL; Mudireddy M; Finke CM; Hanson CA; Ketterling RP; Szuber N; Begna KH; Patnaik MM; Gangat N; Pardanani A; Tefferi A
    Blood Adv; 2018 Feb; 2(4):370-380. PubMed ID: 29467191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Mutational Profile on the Management of Myeloproliferative Neoplasms: A Short Review of the Emerging Data.
    Loscocco GG; Guglielmelli P; Vannucchi AM
    Onco Targets Ther; 2020; 13():12367-12382. PubMed ID: 33293830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary myelofibrosis: 2021 update on diagnosis, risk-stratification and management.
    Tefferi A
    Am J Hematol; 2021 Jan; 96(1):145-162. PubMed ID: 33197049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential Thrombocythemia and Polycythemia Vera: Focus on Clinical Practice.
    Tefferi A; Barbui T
    Mayo Clin Proc; 2015 Sep; 90(9):1283-93. PubMed ID: 26355403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation-enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera.
    Tefferi A; Guglielmelli P; Lasho TL; Coltro G; Finke CM; Loscocco GG; Sordi B; Szuber N; Rotunno G; Pacilli A; Hanson CA; Ketterling RP; Pardanani A; Gangat N; Vannucchi AM
    Br J Haematol; 2020 Apr; 189(2):291-302. PubMed ID: 31945802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broad Next-Generation Integrated Sequencing of Myelofibrosis Identifies Disease-Specific and Age-Related Genomic Alterations.
    Kandarpa M; Robinson D; Wu YM; Qin T; Pettit K; Li Q; Luker G; Sartor M; Chinnaiyan A; Talpaz M
    Clin Cancer Res; 2024 May; 30(9):1972-1983. PubMed ID: 38386293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic stem cell transplantation in patients with myelofibrosis harboring the MPL mutation.
    Mannina D; Gagelmann N; Badbaran A; Ditschkowski M; Bogdanov R; Robin M; Cassinat B; Heuser M; Shahswar R; Thol F; Beelen D; Kröger N
    Eur J Haematol; 2019 Dec; 103(6):552-557. PubMed ID: 31446640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary myelofibrosis: 2017 update on diagnosis, risk-stratification, and management.
    Tefferi A
    Am J Hematol; 2016 Dec; 91(12):1262-1271. PubMed ID: 27870387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ASXL1 mutations in Chinese patients with essential thrombocythemia.
    Nie YB; Sun M; He CK; Ju MK; Zhou FL; Wu SY; Zhou Y; Liu L; Shen H; Huang TT; Liu P; Xu Y; Shao L; Zuo XL
    Exp Ther Med; 2018 May; 15(5):4149-4156. PubMed ID: 29725364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calreticulin exon 9 mutations in myeloproliferative neoplasms.
    Ha JS; Kim YK
    Ann Lab Med; 2015 Jan; 35(1):22-7. PubMed ID: 25553276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of CALR Mutation in Clonal and Nonclonal Hematologic Diseases Using Fragment Analysis and Next-Generation Sequencing.
    Gardner JA; Peterson JD; Turner SA; Soares BL; Lancor CR; Dos Santos LL; Kaur P; Ornstein DL; Tsongalis GJ; de Abreu FB
    Am J Clin Pathol; 2016 Oct; 146(4):448-55. PubMed ID: 27686171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations and thrombosis in essential thrombocythemia: prognostic interaction with age and thrombosis history.
    Gangat N; Wassie EA; Lasho TL; Finke C; Ketterling RP; Hanson CA; Pardanani A; Wolanskyj AP; Maffioli M; Casalone R; Passamonti F; Tefferi A
    Eur J Haematol; 2015 Jan; 94(1):31-6. PubMed ID: 24889737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.